GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Kawin Technology Share-Holding Co Ltd (SHSE:688687) » Definitions » Debt-to-Revenue

Beijing Kawin Technology Share-Holding Co (SHSE:688687) Debt-to-Revenue : 0.17 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Beijing Kawin Technology Share-Holding Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Beijing Kawin Technology Share-Holding Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥154 Mil. Beijing Kawin Technology Share-Holding Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥119 Mil. Beijing Kawin Technology Share-Holding Co's annualized Revenue for the quarter that ended in Sep. 2024 was ¥1,656 Mil. Beijing Kawin Technology Share-Holding Co's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.17.


Beijing Kawin Technology Share-Holding Co Debt-to-Revenue Historical Data

The historical data trend for Beijing Kawin Technology Share-Holding Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Kawin Technology Share-Holding Co Debt-to-Revenue Chart

Beijing Kawin Technology Share-Holding Co Annual Data
Trend Dec13 Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.01 0.04

Beijing Kawin Technology Share-Holding Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.13 0.13 0.17

Competitive Comparison of Beijing Kawin Technology Share-Holding Co's Debt-to-Revenue

For the Biotechnology subindustry, Beijing Kawin Technology Share-Holding Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Kawin Technology Share-Holding Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Kawin Technology Share-Holding Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Beijing Kawin Technology Share-Holding Co's Debt-to-Revenue falls into.


;
;

Beijing Kawin Technology Share-Holding Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Beijing Kawin Technology Share-Holding Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(27.379 + 27.545) / 1412.006
=0.04

Beijing Kawin Technology Share-Holding Co's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(154.484 + 119.192) / 1656.088
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Beijing Kawin Technology Share-Holding Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Beijing Kawin Technology Share-Holding Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Kawin Technology Share-Holding Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Rongjing East Street, Building 3, Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Beijing Kawin Technology Share-Holding Co Ltd is a biotechnology company. It offers healthcare solutions for liver disease. The company's products include Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound glycyrrhizin capsules.
Executives
Liu Shan Core technical personnel
Li Xiang Core technical personnel

Beijing Kawin Technology Share-Holding Co Headlines

No Headlines